Literature DB >> 1329036

Incomplete reversion of double stranded DNA cleavage mediated by Drosophila topoisomerase II: formation of single stranded DNA cleavage complex in the presence of an anti-tumor drug VM26.

M P Lee1, T Hsieh.   

Abstract

Anti-tumor drug VM26 greatly stimulates topoisomerase II mediated DNA cleavage by stabilizing the cleavable complex. Addition of a strong detergent such as SDS to the cleavable complex induces the double stranded DNA cleavage. We demonstrate here that heat treatment can reverse the double stranded DNA cleavage; however, topoisomerase II remains bound to DNA even in the presence of SDS. This reversed complex has been shown to contain single strand DNA breaks with topoisomerase II covalently linked to the nicked DNA. Chelation of Mg++ by EDTA and the addition of salt to a high concentration also reverse the double strand DNA cleavage, and like heat reversion, topoisomerase II remains bound to DNA through single strand DNA break. The reversion complex can be analyzed and isolated by CsCl density gradient centrifugation. We have detected multiple discrete bands from such a gradient, corresponding to protein/DNA complexes with 1, 2, 3, ..... topoisomerase II molecules bound per DNA molecule. Analysis of topoisomerase II/DNA complexes isolated from the CsCl gradient indicates that there are single stranded DNA breaks associated with the CsCl stable complexes. Therefore, topoisomerase II/DNA complex formed in the presence of VM26 cannot be completely reversed to yield free DNA and enzyme. We discuss the possible significance of this finding to the mechanism of action of VM26 in the topoisomerase II reactions.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1329036      PMCID: PMC334279          DOI: 10.1093/nar/20.19.5027

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  29 in total

Review 1.  DNA topoisomerase poisons as antitumor drugs.

Authors:  L F Liu
Journal:  Annu Rev Biochem       Date:  1989       Impact factor: 23.643

2.  DNA topoisomerase II is required at the time of mitosis in yeast.

Authors:  C Holm; T Goto; J C Wang; D Botstein
Journal:  Cell       Date:  1985-06       Impact factor: 41.582

3.  Inhibitors of topoisomerase II: structure-activity relationships and mechanism of action of podophyllin congeners.

Authors:  B H Long; D A Stringfellow
Journal:  Adv Enzyme Regul       Date:  1988

4.  In situ localization of DNA topoisomerase II, a major polypeptide component of the Drosophila nuclear matrix fraction.

Authors:  M Berrios; N Osheroff; P A Fisher
Journal:  Proc Natl Acad Sci U S A       Date:  1985-06       Impact factor: 11.205

5.  Single strand DNA cleavage reaction of duplex DNA by Drosophila topoisomerase II.

Authors:  M P Lee; M Sander; T S Hsieh
Journal:  J Biol Chem       Date:  1989-08-15       Impact factor: 5.157

6.  Evidence for the reversibility of cellular DNA lesion induced by mammalian topoisomerase II poisons.

Authors:  Y H Hsiang; L F Liu
Journal:  J Biol Chem       Date:  1989-06-15       Impact factor: 5.157

7.  Nuclease protection by Drosophila DNA topoisomerase II. Enzyme/DNA contacts at the strong topoisomerase II cleavage sites.

Authors:  M P Lee; M Sander; T Hsieh
Journal:  J Biol Chem       Date:  1989-12-25       Impact factor: 5.157

8.  DNA topoisomerase II mutant of Saccharomyces cerevisiae: topoisomerase II is required for segregation of daughter molecules at the termination of DNA replication.

Authors:  S DiNardo; K Voelkel; R Sternglanz
Journal:  Proc Natl Acad Sci U S A       Date:  1984-05       Impact factor: 11.205

9.  The organisation of chromatin loops: characterization of a scaffold attachment site.

Authors:  S M Gasser; U K Laemmli
Journal:  EMBO J       Date:  1986-03       Impact factor: 11.598

10.  Cytofluorometric studies on the action of podophyllotoxin and epipodophyllotoxins (VM-26, VP-16-213) on the cell cycle traverse of human lymphoblasts.

Authors:  A Krishan; K Paika; E Frei
Journal:  J Cell Biol       Date:  1975-09       Impact factor: 10.539

View more
  4 in total

1.  Functional interactions of DNA topoisomerases with a human replication origin.

Authors:  Gulnara Abdurashidova; Sorina Radulescu; Oscar Sandoval; Sotir Zahariev; Miltcho B Danailov; Alexander Demidovich; Laura Santamaria; Giuseppe Biamonti; Silvano Riva; Arturo Falaschi
Journal:  EMBO J       Date:  2007-02-08       Impact factor: 11.598

2.  Inactivation of topoisomerase I or II may lead to recombination or to aberrant replication termination on both SV40 and yeast 2 micron DNA.

Authors:  P Levac; T Moss
Journal:  Chromosoma       Date:  1996-10       Impact factor: 4.316

3.  Topoisomerase IIbeta activates a subset of neuronal genes that are repressed in AT-rich genomic environment.

Authors:  Kuniaki Sano; Mary Miyaji-Yamaguchi; Kimiko M Tsutsui; Ken Tsutsui
Journal:  PLoS One       Date:  2008-12-31       Impact factor: 3.240

4.  Toward discovering new anti-cancer agents targeting topoisomerase IIα: a facile screening strategy adaptable to high throughput platform.

Authors:  Yu-Shih Lin; Wan-Chen Huang; Mei-Shya Chen; Tao-Shih Hsieh
Journal:  PLoS One       Date:  2014-05-08       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.